Next 10 |
2024-03-21 12:17:05 ET More on LAVA Therapeutics Lava gets $7M from Pfizer as trial for cancer drug advances LAVA stock rises on clinical trial collaboration with Merck Seeking Alpha’s Quant Rating on LAVA Therapeutics Historical earnings data for LAVA...
2024-03-20 10:20:00 ET March 20, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies are involved in immuno-oncology, ...
LAVA-1207 progressing in Phase 1/2a study, with pembrolizumab combination expected to begin in Q2 2024 In March 2024, Pfizer paid LAVA $7 million for achieving a clinical milestone for EGFRd2 (PF-08046052/formerly LAVA-1223) LAVA 1266 tracking to Q2 2024 IND submission...
2024-03-05 10:28:49 ET More on LAVA Therapeutics LAVA stock rises on clinical trial collaboration with Merck Seeking Alpha’s Quant Rating on LAVA Therapeutics Historical earnings data for LAVA Therapeutics Financial information for LAVA Therapeutics ...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 61.6% to $0.143 on volume of 387,468,585 shares Fisker Inc. Class A (FSR) fell 8.5% to $0.4415 on volume of 205,557,321 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.0% to $3.22 on vol...
2024-03-05 08:30:57 ET Palm Beach, FL – March 5, 2024 – FN Media Group News Commentary – Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other parts of the world is one of t...
UTRECHT, The Netherlands and PHILADELPHIA, March 05, 2024 (GLOBE NEWSWIRE) -- LAVA Therapeutics N.V. (NASDAQ: LVTX, “LAVA”), a clinical-stage immuno-oncology company focused on developing its proprietary Gammabody® platform of bispecific gamma delta T cell engagers, today a...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 58.0% to $0.1398 on volume of 323,150,710 shares Fisker Inc. Class A (FSR) fell 6.7% to $0.45 on volume of 175,737,100 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 6.2% to $3.115 on vol...
A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 33.7% to $0.4825 on volume of 369,944,141 shares Jaguar Health Inc. (JAGX) rose 50.0% to $0.0885 on volume of 303,339,477 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 12.6% to $3.32 on ...
A look at the top 10 most actives in the United States Enveric Biosciences Inc. (ENVB) rose 74.5% to $1.45 on volume of 176,922,601 shares SoundHound AI Inc. (SOUN) rose 17.0% to $7.42 on volume of 176,458,528 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 7.8% to $3.8 on ...
News, Short Squeeze, Breakout and More Instantly...
LAVA Therapeutics N.V. Company Name:
LVTX Stock Symbol:
NASDAQ Market:
2024-03-20 10:20:00 ET March 20, 2024 (Investorideas.com Newswire) Investorideas.com , a global news source and expert investing resource, announces today's roundup of stocks to watch in the Biotech/Life Sciences sector. The newest biotech companies are involved in immuno-oncology, ...
LAVA-1207 progressing in Phase 1/2a study, with pembrolizumab combination expected to begin in Q2 2024 In March 2024, Pfizer paid LAVA $7 million for achieving a clinical milestone for EGFRd2 (PF-08046052/formerly LAVA-1223) LAVA 1266 tracking to Q2 2024 IND submission...
A look at the top 10 most actives in the United States Jaguar Health Inc. (JAGX) rose 61.6% to $0.143 on volume of 387,468,585 shares Fisker Inc. Class A (FSR) fell 8.5% to $0.4415 on volume of 205,557,321 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) fell 3.0% to $3.22 on vol...